Mark Sausen

13.4k total citations · 1 hit paper
51 papers, 3.1k citations indexed

About

Mark Sausen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Sausen has authored 51 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cancer Research, 25 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Sausen's work include Cancer Genomics and Diagnostics (36 papers), Genetic factors in colorectal cancer (13 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Mark Sausen is often cited by papers focused on Cancer Genomics and Diagnostics (36 papers), Genetic factors in colorectal cancer (13 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Mark Sausen collaborates with scholars based in United States, Netherlands and Canada. Mark Sausen's co-authors include Victor E. Velculescu, Luis A. Díaz, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Siân Jones, Isaac Kinde, Nishant Agrawal, Chetan Bettegowda and Rebecca Leary and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Mark Sausen

44 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing

2012 474 citations Mark Sausen, Nickolas Papadopoulos et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Sausen United States	20	1.8k	1.2k	1.2k	921	590	51	3.1k
Roland Penzel Germany	40	1.3k 0.7×	1.7k 1.4×	1.8k 1.5×	1.5k 1.6×	771 1.3×	134	4.4k
Nicolò Riggi Switzerland	27	1.5k 0.8×	3.2k 2.6×	1.2k 1.0×	1.4k 1.5×	335 0.6×	50	4.7k
Volker Endris Germany	35	1.4k 0.7×	1.2k 0.9×	1.7k 1.5×	1.1k 1.1×	676 1.1×	99	3.4k
Enrico Orvieto Italy	29	1.4k 0.8×	483 0.4×	1.2k 1.0×	658 0.7×	1.2k 2.1×	69	3.1k
Joanne Xiu United States	29	886 0.5×	995 0.8×	2.2k 1.9×	1.2k 1.3×	862 1.5×	257	3.8k
Socorro Marıá Rodríguez-Pinilla Spain	30	1.1k 0.6×	1.6k 1.3×	2.0k 1.7×	341 0.4×	1.1k 1.9×	97	3.8k
David Piccioni United States	25	1.1k 0.6×	821 0.7×	998 0.9×	861 0.9×	299 0.5×	94	2.7k
Lara Felicioni Italy	26	1.4k 0.7×	1.6k 1.3×	1.9k 1.6×	2.2k 2.4×	373 0.6×	37	3.7k
Paula Marrano Canada	26	842 0.5×	1.6k 1.3×	2.0k 1.7×	2.2k 2.4×	237 0.4×	60	4.0k
Tim Forshew United Kingdom	23	4.1k 2.2×	2.6k 2.0×	2.2k 1.9×	2.1k 2.3×	1.0k 1.7×	34	5.9k

Countries citing papers authored by Mark Sausen

Since Specialization

Citations

This map shows the geographic impact of Mark Sausen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sausen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sausen more than expected).

Fields of papers citing papers by Mark Sausen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sausen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sausen. The network helps show where Mark Sausen may publish in the future.

Co-authorship network of co-authors of Mark Sausen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sausen. A scholar is included among the top collaborators of Mark Sausen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sausen. Mark Sausen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jackson, Jennifer, Cynthia Maddox, James R. White, et al.. (2025). Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology. Journal of Molecular Diagnostics. 27(3). 216–231. 1 indexed citations

Baden, Jonathan, Mark Sausen, Andrew Anfora, et al.. (2025). Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays. Journal of Molecular Diagnostics. 27(10). 914–919. 1 indexed citations

Ketelaars, Steven L. C., Gerrit A. Meijer, Mark Sausen, et al.. (2024). Abstract 2496: Molecular characterization of stage III colon cancer patients with recurrence after adjuvant chemotherapy. Cancer Research. 84(6_Supplement). 2496–2496.

Baehner, Frederick L., James Chen, Carin R. Espenschied, et al.. (2024). Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages. Diagnostics. 14(9). 912–912. 1 indexed citations

Anagnostou, Valsamo, Cheryl Ho, Garth Nicholas, et al.. (2023). ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. Nature Medicine. 29(10). 2559–2569. 66 indexed citations

Tao, Jessica J., Jenna VanLiere Canzoniero, Archana Balan, et al.. (2023). Liquid biopsy-informed precision oncology study to evaluate utility of plasma genomic profiling for therapy selection.. Journal of Clinical Oncology. 41(16_suppl). TPS1616–TPS1616.

Sivapalan, Lavanya, Joseph C. Murray, Jenna VanLiere Canzoniero, et al.. (2023). Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 11(1). e005924–e005924. 66 indexed citations

Nesline, Mary, Paul DePietro, Maureen Cooper, et al.. (2023). The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program.. Journal of Clinical Oncology. 41(16_suppl). 6506–6506. 1 indexed citations

Severson, Eric A., Bhagelu R. Achyut, Mary Nesline, et al.. (2023). RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers. Journal of Molecular Diagnostics. 25(7). 454–466. 8 indexed citations

10.

Jackson, Jennifer, Eric A. Severson, Amy Greer, et al.. (2023). Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors. Journal of Molecular Diagnostics. 25(7). 477–489. 2 indexed citations

11.

Erve, Iris van ’t, Jamie E. Medina, Alessandro Leal, et al.. (2022). Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells. Clinical Cancer Research. 29(5). 899–909. 22 indexed citations

12.

Phallen, Jillian, Mark Sausen, John K. Simmons, et al.. (2020). 521TiP Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer according the trials within cohorts design: The MEDOCC-CrEATE trial. Annals of Oncology. 31. S460–S460. 5 indexed citations

13.

Georgiadis, Andrew, Jennifer N. Durham, Laurel A. Keefer, et al.. (2019). Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade. Clinical Cancer Research. 25(23). 7024–7034. 110 indexed citations

14.

Wood, Derrick E., James R. White, Andrew Georgiadis, et al.. (2018). A machine learning approach for somatic mutation discovery. Science Translational Medicine. 10(457). 67 indexed citations

15.

Hamm, Christopher A., Diarmuid Moran, Patricia B. Trusk, et al.. (2016). Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors. Molecular Cancer Therapeutics. 15(7). 1746–1756. 44 indexed citations

16.

Kang, Hyunseok, Marietta Tan, Justin A. Bishop, et al.. (2016). Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma. Clinical Cancer Research. 23(1). 283–288. 67 indexed citations

17.

Parpart-Li, Sonya, Bjarne R. Bartlett, Maria Popoli, et al.. (2016). The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA. Clinical Cancer Research. 23(10). 2471–2477. 145 indexed citations

18.

Rettig, Eleni M., C. Conover Talbot, Mark Sausen, et al.. (2016). Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma. Cancer Prevention Research. 9(4). 265–274. 68 indexed citations

19.

Zhang, Ming, Yuxuan Wang, Siân Jones, et al.. (2014). Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nature Genetics. 46(11). 1170–1172. 206 indexed citations

20.

Bettegowda, Chetan, Nishant Agrawal, Yuchen Jiao, et al.. (2011). Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma. Science. 333(6048). 1453–1455. 370 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact